.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Julphar
Healthtrust
Novartis
Baxter
Fish and Richardson
Farmers Insurance
Fuji
Federal Trade Commission

Generated: December 14, 2017

DrugPatentWatch Database Preview

Amlodipine besylate; telmisartan - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for amlodipine besylate; telmisartan and what is the scope of amlodipine besylate; telmisartan freedom to operate?

Amlodipine besylate; telmisartan
is the generic ingredient in two branded drugs marketed by Alembic Pharms Ltd, Lupin Ltd, Mylan Pharms Inc, Torrent Pharms Ltd, and Boehringer Ingelheim, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty drug master file entries for amlodipine besylate; telmisartan. Six suppliers are listed for this compound.

Summary for amlodipine besylate; telmisartan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms IncTELMISARTAN AND AMLODIPINEamlodipine besylate; telmisartanTABLET;ORAL202516-004Aug 26, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-001Oct 16, 2009ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-003Oct 16, 2009ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Torrent Pharms LtdTELMISARTAN AND AMLODIPINEamlodipine besylate; telmisartanTABLET;ORAL202517-001Jan 8, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-004Oct 16, 2009ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Alembic Pharms LtdTELMISARTAN AND AMLODIPINEamlodipine besylate; telmisartanTABLET;ORAL205234-002Nov 17, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Alembic Pharms LtdTELMISARTAN AND AMLODIPINEamlodipine besylate; telmisartanTABLET;ORAL205234-004Nov 17, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-002Oct 16, 2009ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Lupin LtdTELMISARTAN AND AMLODIPINEamlodipine besylate; telmisartanTABLET;ORAL201586-004Jan 8, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Torrent Pharms LtdTELMISARTAN AND AMLODIPINEamlodipine besylate; telmisartanTABLET;ORAL202517-004Jan 8, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: amlodipine besylate; telmisartan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-001Oct 16, 2009► Subscribe► Subscribe
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-004Oct 16, 2009► Subscribe► Subscribe
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-002Oct 16, 2009► Subscribe► Subscribe
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-003Oct 16, 2009► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Accenture
Chubb
Medtronic
Deloitte
Baxter
Merck
Novartis
Julphar
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot